- Home
- GTBP vs GGRP Comparison
GTBP vs GGRP Comparison
Compare GTBP & GGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.42
N/A
Current Price
$0.61
Company Overview
Basic Information| Metric | GTBP | GGRP |
|---|---|---|
| Founded | 1965 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1M | 12.5M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GTBP | GGRP |
|---|---|---|
| Price | $0.42 | $0.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 799.3K | 79.3K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $72.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $0.54 |
| 52 Week High | $3.73 | $0.64 |
Technical Indicators
Market Signals| Indicator | GTBP | GGRP |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 48.40 |
| Support Level | $0.41 | $0.55 |
| Resistance Level | $0.59 | $0.64 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 6.00 | 49.50 |
Price Performance
Historical Comparison GTBP
GGRP
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.